Analysis of the susceptibility of CD57+ T cells to CD3-mediated apoptosis

Clinical and Experimental Immunology

Volumn 139, Issue 2, 2005, Pages 268-278

  Shinomiya, N ^a   Koike, Y ^a   Koyama, H ^b   Takayama, E ^a   Habu, Y ^a   Fukasawa, M ^a   Tanuma, S ^b   Seki, Shuhji ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

CD3 mediated apoptosis; CD57+ T cells; Fas FasL; NKT cells; Survivin

Indexed keywords

CASPASE 3; CD3 ANTIGEN; CD3 EPSILON ANTIGEN; CD3 ZETA ANTIGEN; CD57 ANTIGEN; FAS ANTIGEN; FAS LIGAND; SURVIVIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL SCREENING; CELL SELECTION; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIBODIES; ANTIGENS, CD3; ANTIGENS, CD57; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASES; CELLS, CULTURED; FAS LIGAND PROTEIN; HUMANS; IMMUNOGLOBULIN EPSILON-CHAINS; IMMUNOGLOBULIN GAMMA-CHAINS; MEMBRANE GLYCOPROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 13544275016     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02687.x     Document Type: Article

References (57)

1. Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981; 127:1024-9.
2. Abo T, Watanabe H, Iiai T et al. Extrathymic pathways of T-cell differentiation in the liver and other organs. Int Rev Immunol 1994; 11:61-102.
3. Miyaji C, Watanabe H, Toma H et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol 2000; 61:908-16.
4. + T cells. Immunology 2001; 103:281-90.
5. Miyaji C, Watanabe H, Minagawa M et al. Numerical and functional characteristics of lymphocyte subsets in centenarians. J Clin Immunol 1997; 17:420-9.
6. + T cells augment IFN-gamma production in a one-way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients. Clin Exp Immunol 2002; 130:162-8.
7. Ami K, Ohkawa T, Koike Y et al. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18. Clin Exp Immunol 2002; 128:453-9.
8. + T cells. Immunology 2003; 108:211-19.
9. Nakagawa R, Nagafune I, Tazunoki Y et al. Mechanisms of the anti-metastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol 2001; 166:6578-84.
10. Inui T, Nakagawa R, Ohkura S et al. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag (+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro. J Immunol 2002; 169:6127-32.
11. + T cells for the antitumor immunity induced in the liver of mice by alpha-galactosylceramide. J Immunol 2004; 172:6550-7.
12. Osman Y, Kawamura T, Naito T et al. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur J Immunol 2000; 30:1919-28.
13. Crowe NY, Uldrich AP, Kyparissoudis K et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 2003; 171:4020-7.
14. Wilson MT, Johansson C, Olivares-Villagomez D et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci USA 2003; 100:10913-18.
15. + T cells in mice by interleukin-12 pretreatment. Immunology 2004; 113:35-43.
16. Brunner T, Mogil RJ, LaFace D et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373:441-4.
17. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373:438-41.
18. Ju ST, Panka DJ, Cui H et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373:444-8.
19. + suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. J Immunol 1986; 137:2180-9.
20. + (Leu-7) and other lymphocyte subsets in long-term survivors with renal allotransplants. Transplantation 1985; 39:25-9.
21. + lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum 1993; 36:608-12.
22. + T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory role. Clin Exp Immunol 1998; 111:345-52.
23. + T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. Eur J Immunol 1994; 24:2882-8.
24. + granular lymphocytes: a requirement for their proliferation. J Immunol 1983; 131:1822-6.
25. + cells with natural killer cell-related features. Divergence from typical T helper cells. J Immunol 1986; 137:2808-13.
26. + T cells. Blood 2003; 101:2711-20.
27. + T cells: effector T cells. Int Immunol 1998; 10:1837-45.
28. Ruthlein J, James SP, Strober W. Role of CD2 in activation and cytotoxic function of CD8/Leu-7-positive T cells. J Immunol 1988; 141:3791-7.
29. Herndon FJ, Hsu HC, Mountz JD. Increased apoptosis of CD45RO- T cells with aging. Mech Ageing Dev 1997; 94:123-34.
30. Phelouzat MA, Arbogast A, Laforge T, Quadri RA, Proust JJ. Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev 1996; 88:25-38.
31. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 1998; 160:1627-37.
32. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995; 14:1129-35.
33. Suda T, Okazaki T, Naito Y et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154:3806-13.
34. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995; 181:781-6.
35. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3:917-21.
36. Tamm I, Wang Y, Sausville E et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58:5315-20.
37. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13:230-40.
38. Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998; 92:4771-7.
39. + T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production. J Immunol 2000; 164:5652-8.
40. Kawarabayashi N, Seki S, Hatsuse K et al. Decrease of CD56(+) T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000; 32:962-9.
41. +T cells in T helper 1 immune responses. Immunol Rev 2000; 174:35-46.
42. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-17.
43. Seki S, Abo T, Ohteki T, Sugiura K, Kumagai K. Unusual alpha beta-T cells expanded in autoimmune lpr mice are probably a counterpart of normal T cells in the liver. J Immunol 1991; 147:1214-21.
44. Tsukahara A, Seki S, Iiai T et al. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 1997; 26:301-9.
45. Matsuda M, Ulfgren AK, Lenkei R et al. Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol 1998; 47:254-62.
46. Frydecka I, Kaczmarek P, Bocko D, Kosmaczewska A, Morilla R, Catovsky D. Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease. Leuk Lymphoma 1999; 35:545-54.
47. Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 1996; 2:161-73.
48. Buggins AG, Hirst WJ, Pagliuca A, Mufti GJ. Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies. Br J Haematol 1998; 100:784-92.
49. + subset. J Immunol 1995; 154:6182-90.
50. Abo T, Kawamura T, Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev 2000; 174:135-49.
51. Malissen B, Schmitt-Verhulst AM. Transmembrane signalling through the T-cell-receptor-CD3 complex. Curr Opin Immunol 1993; 5:324-33.
52. Klausner RD, Lippincott-Schwartz J, Bonifacino JS. The T cell antigen receptor: insights into organelle biology. Annu Rev Cell Biol 1990; 6:403-31.
53. Takahashi A, Kono K, Amemiya H, Iizuka H, Fujii H, Matsumoto Y. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer. Clin Cancer Res 2001; 7:74-80.
54. + peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res 2001; 7:S947-57.
55. Aoe T, Okamoto Y, Saito T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 1995; 181:1881-6.
56. Moingeon P, Lucich JL, McConkey DJ et al. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc Natl Acad Sci USA 1992; 89:1492-6.
57. Cruz-Munoz ME, Salas-Vidal E, Salaiza-Suazo N, Becker I, Pedraza-Alva G, Rosenstein Y. The CD43 coreceptor molecule recruits the zeta-chain as part of its signaling pathway. J Immunol 2003; 171:1901-8.